Increased risk of myocardial infarction with dabigatran etexilate: fact or fiction? A critical meta-analysis of over 580,000 patients from integrating randomized controlled …

AH Wei, ZC Gu, C Zhang, YF Ding, D Liu, J Li… - International Journal of …, 2018 - Elsevier
Background The question of whether the use of dabigatran etexilate is associated with a
high risk of myocardial infarction (MI) remains unanswered owing to the lack of critical …

[PDF][PDF] Increased Risk of Myocardial Infarction with Dabigatran etexilate: Fact or Fiction? A Critical Meta-analysis of Over 580,000 Patients From Integrating …

AH Wei, ZC Gu, C Zhang, YF Ding, D Liu, J Li, XY Liu - 2018 - researchgate.net
Accepted Manuscript Page 1 Accepted Manuscript Increased risk of myocardial infarction with
dabigatran etexilate: fact or fiction? A critical meta-analysis of over 580,000 patients from …

Increased risk of myocardial infarction with dabigatran etexilate: fact or fiction? A critical meta-analysis of over 580,000 patients from integrating randomized controlled …

AH Wei, ZC Gu, C Zhang, YF Ding… - International …, 2018 - pubmed.ncbi.nlm.nih.gov
Background The question of whether the use of dabigatran etexilate is associated with a
high risk of myocardial infarction (MI) remains unanswered owing to the lack of critical …

Increased risk of myocardial infarction with dabigatran etexilate: fact or fiction? A critical meta-analysis of over 580,000 patients from integrating randomized controlled …

AH Wei, ZC Gu, C Zhang, YF Ding, D Liu… - … Journal of Cardiology, 2018 - europepmc.org
Background The question of whether the use of dabigatran etexilate is associated with a
high risk of myocardial infarction (MI) remains unanswered owing to the lack of critical …

Increased risk of myocardial infarction with dabigatran etexilate: fact or fiction? A critical meta-analysis of over 580,000 patients from integrating randomized controlled …

AH Wei, ZC Gu, C Zhang… - International …, 2018 - internationaljournalofcardiology.com
Background The question of whether the use of dabigatran etexilate is associated with a
high risk of myocardial infarction (MI) remains unanswered owing to the lack of critical …